Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about LEXX Recent news which mentions LEXX < Previous 1 2 3 4 Next > Lexaria Bioscience's 24th Patent Sets Stage For Market Opportunities In Australia March 31, 2022 Tickers LEXX Tags InvestorBrandNetwork Biotech Partner Content From Benzinga Lexaria Bioscience Optimistic About Upcoming Hypertension Study March 28, 2022 Tickers LEXX Tags InvestorBrandNetwork Biotech Market News From Benzinga Lexaria's IP Portfolio Grows Following Receipt Of 24th Granted Patent March 22, 2022 Tickers LEXX Tags Benzinga LEXX General From Benzinga Lexaria Bioscience Commences DehydraTECH-CBD Epilepsy Research Program March 16, 2022 Tickers LEXX LEXXW Tags LEXX General Partner Content From Benzinga Lexaria Bioscience Receives Award For Oral Nicotine Compound Patent March 09, 2022 Tickers LEXX Tags Biotech InvestorBrandNetwork Partner Content From Benzinga Studies Advance Lexaria Bioscience's Tech For Improving Pharmaceutical Drugs March 07, 2022 Tickers LEXX Tags InvestorBrandNetwork Biotech Market News From Benzinga Lexaria's DehydraTECH(TM) Demonstrates Faster Delivery Of Sildenafil March 04, 2022 Tickers LEXX TM Tags Benzinga General LEXX From Benzinga Lexaria Bioscience Optimistic Of Positive Study Results February 28, 2022 Tickers LEXX Tags Partner Content InvestorBrandNetwork LEXX From Benzinga Lexaria Optimistic About Expanded DehydraTECH Investigations February 23, 2022 Tickers LEXX Tags Penny Stocks Benzinga LEXX From Benzinga Lexaria World Leader Through DehydraTECH(TM) – Its Pioneering Drug Delivery Tech February 22, 2022 Tickers LEXX TM Tags Penny Stocks Benzinga LEXX From Benzinga Following Sildenafil Study, Lexaria Announces Plans For More Studies In 2022 February 17, 2022 Tickers LEXX Tags Partner Content Market News InvestorBrandNetwork From Benzinga Lexaria's DehydraTECH(TM) To Be Evaluated As Treatment For Multiple Conditions February 14, 2022 Tickers LEXX TM Tags General LEXX Benzinga From Benzinga Lexaria Technology Shows Promise In Improving Performance Of ED Drugs February 11, 2022 Tickers LEXX Tags Penny Stocks LEXX General From Benzinga Lexaria CEO Summarizes 2021 Milestones in Letter to Shareholders February 09, 2022 Tickers LEXX Tags Penny Stocks Benzinga Market News From Benzinga Lexaria Bioscience Announces Significant Findings From Sildenafil Animal Study February 03, 2022 Tickers LEXX Tags Partner Content Market News InvestorBrandNetwork From Benzinga Lexaria CEO Offers A Glimpse Into Company's Unique Tech On EDGE Podcast February 01, 2022 Tickers LEXX Tags Penny Stocks General LEXX From Benzinga Lexaria Emphasizes Oral Cannabinoid Benefits Following SARS-CoV-2 Study January 28, 2022 Tickers LEXX Tags LEXX Partner Content InvestorBrandNetwork From Benzinga Lexaria Bioscience Marks Great Start to its 2022 R&D Programs January 21, 2022 Tickers LEXX Tags LEXX General News From Benzinga Lexaria Bioscience Comments on Study Examining Cannabinoids and SARS-CoV-2 January 19, 2022 Tickers LEXX Tags LEXX General Biotech From Benzinga Lexaria Bioscience Leveraging DehydraTECH(TM) for More Effective Oral Medicine January 18, 2022 Tickers LEXX TM Tags General LEXX Partner Content From Benzinga Lexaria Bioscience Celebrates Productive Year for Blood Pressure Drug Solution January 12, 2022 Tickers LEXX Tags Market News Cannabis Markets From Benzinga Lexaria Bioscience (NASDAQ: LEXX) Receives Independent Review Board Approval for Human Study January 11, 2022 Tickers LEXX Tags Partner Content Market News InvestorBrandNetwork From Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session January 07, 2022 Tickers ATOS AXSM CFRX ENSC Tags RSLS CFRX Movers From Benzinga Lexaria Bioscience Increases Investor Visibility with SRAX January 07, 2022 Tickers LEXX SRAX Tags InvestorBrandNetwork Biotech Partner Content From Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 06, 2022 Tickers ATOS BVXV CEMI CFRX Tags Movers SXTC CEMI From Benzinga Lexaria Bioscience Announces Approval from Independent Review for DehydraTECH-CBD Study December 30, 2021 Tickers LEXX Tags Partner Content Biotech InvestorBrandNetwork From Benzinga Lexaria Bioscience Expects Study Results to Show Patented Tech's Value in Treating Hypertension December 28, 2021 Tickers LEXX Tags Market News Benzinga Penny Stocks From Benzinga Lexaria Bioscience Announces Major Discovery; Increasing Effectiveness of Orally Administered CBD December 23, 2021 Tickers LEXX Tags Markets Cannabis Market News From Benzinga Lexaria's DehydraTECH(TM) CBD Found to Reduce Arterial Stiffness in Study December 17, 2021 Tickers LEXX TM Tags Market News Benzinga Penny Stocks From Benzinga Lexaria Bioscience Committed to Innovation and Improving Quality of Life December 15, 2021 Tickers LEXX Tags LEXX Events Partner Content From Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.